M. Javad Aman plays a dual role of both running the business and leading the science at Integrated BioTherapeutics. He works to further the development of novel vaccines and immunotherapy for emerging infectious diseases. Current lead vaccine candidates include a multivalent vaccine for S. aureus infections as well as trivalent vaccine and antibody therapeutic for filovirus hemorrhagic fever.
